Primary peritoneal mesothelioma: Case series and literature review;Mésothéliome primitif du péritoine: analyse de six cas consécutifs et revue de la littérature

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 1, 2011, Pages 55-59

  Sharma, H ^a   Bell, I ^a   Schofield, J ^a   Bird, G ^a  

^a MAIDSTONE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CA 125 ANTIGEN; CALRETININ; CARBOPLATIN; CISPLATIN; MITOMYCIN; NAVELBINE; TUMOR MARKER; VINBLASTINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABDOMINAL SWELLING; ADULT; AGED; ARTICLE; ASCITES; ASCITES FLUID; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DECREASED APPETITE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LIVER CYST; LUNG LESION; MALE; MULTIPLE CYCLE TREATMENT; OMENTECTOMY; OVARY TUMOR; PARACENTESIS; PERITONEAL BIOPSY; PERITONEUM MESOTHELIOMA; PLEURA PLAQUE; PRIMARY TUMOR; PROTEIN BLOOD LEVEL; RETROPERITONEAL FAT; SALPINGOOOPHORECTOMY; THROMBOCYTE COUNT; THROMBOCYTOSIS; TUMOR GROWTH; TUMOR VOLUME; ULTRASOUND; WEIGHT REDUCTION;

AGED; FATAL OUTCOME; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PERITONEAL NEOPLASMS;

EID: 79956020921     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.07.016     Document Type: Article

References (22)

1. Cunha P., Luz Z., Seves I., Sousa C., Skiappa R., Ribeiro L., et al. Malignant peritoneal mesothelioma - diagnostic and therapeutic difficulties. Acta Med Port 2002, 15:383-386.
2. Antman K.H., Pomfret E.A., Aisner J., MacIntyre J., Osteen R.T., Greenburger J.S. Peritoneal mesothelioma: natural history and response to chemotherapy. J Clin Oncol 1983, 1:386-391.
3. Statement on malignant mesothelioma in the United Kingdom. Thorax 2007, 62:ii1-ii19. British Thoracic Society Standards of Care Committee.
4. Naka H., Naka A. Clinicopathological study on 100 Japanese patients with peritoneal mesothelioma in Japan. Gan No Rinsho 1984, 30:1-10.
5. De Pangher Manzini V. Malignant peritoneal mesothelioma. Tumori 2005, 91:1-5.
6. Sussman J., Rosai J. Lymph node metastasis as the initial manifestation of malignant mesothelioma. Report of six cases. Am J Surg Pathol 1990, 14:818-828.
7. Metintas S., Metintas M., Ucgun I., Oner U. Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest 2002, 122:2224-2229.
8. Schneiderman H. Mesothelioma and venous thrombosis. CMAJ 2004, 171:11.
9. Tandar A., Abraham G., Gurka J., Wendel M., Stolbach L. Recurrent peritoneal mesothelioma with long-delayed recurrence. J Clin Gastroenterol 2001, 33:247-250.
10. Hassan R., Alexander R., Antman K., Boffetta P., Churg A., Coit D., et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol 2006, 17:1615-1619.
11. Chahinian A.P., Pajak T.F., Holland J.F., Norton L., Ambinder R.M., Mandel E.M. Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med 1982, 96:746-755.
12. Henderson D.W., Shilkin K.B., Whitaker D. The pathology of malignant mesothelioma including immunohistochemistry and ultra-structure. Malignant mesothelioma 1992, 69-139. Hemisphere, New York, NY. D.W. Henderson, K.G. Shilkin, S.L.D. Langlois, D. Whitaker (Eds.).
13. Chu P.G., Weiss L.M. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol 2002, 15:6-10.
14. Carella R., Deleonardi G., D'Errico A., Salerno A., Egarter-Vigl E., Seebacher C., et al. Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma. Am J Surg Pathol 2001, 25:43-50.
15. Ordonez N.G. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol 1998, 10:1215-1221.
16. Hassan R., Remaley A.T., Sampson M.L., Zhang J., Cox D.D., Pingpank J., et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 2006, 12(2):447-453.
17. Taub R.N., Keohan M.L., Chabot J.C., Fountain K.S., Plitsas M. Peritoneal mesothelioma. Curr Treat Options Oncol 2000, 1:303-312.
18. Zellos L.S., Sugarbaker D.J. Diffuse malignant mesothelioma of the pleural space and its management. Oncology 2002, 16:907-925.
19. Tang C.K., Gray G.F., Keuhnelian J.G. Malignant peritoneal mesothelioma in an inguinal hernia sac. Cancer 1976, 37(4):1887-1890.
20. Kasdon E.J. Malignant mesothelioma of the tunica vaginalis propria testis. Cancer 1969, 23:1144-1150.
21. Hesdorffer M.E., Chabot J.A., Keohan M.L., Fountain K., Talbot S., Gabay M., et al. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma. Am J Clin Oncol 2008, 31(1):49-54.
22. Feldman A.L., Libutti S.K., Pingpank J.F., Bartlett D.L., Beresnev T.H., Mavroukakis S.M., et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003, 21(24):4560-4567.